Thomas Jefferson University
Department of Medical Oncology
The mission of Jefferson's
Department of Medical Oncology is:
- To provide state-of-the-art care in our discipline while simultaneously working to improve the state-of-the-art through clinical and bench investigation, advancing the field rather than simply adopting the work of others;
- To ensure that our patients will be the beneficiaries of outstanding care provided in a warm, compassionate, and stress reducing environment;
- To provide physicians in training and medical students with an education reflective of high standards; to conduct ourselves as role models whom they can emulate, and to help instill in them a similar passion to always strive to be the best physicians they can be.
The Department of Medical Oncology works closely with the Kimmel Cancer Center, other participants in the Cancer Service Line, and the Division of Hematology in its clinical, research, and educational activities, treating patients using a multidisciplinary approach with Jefferson physicians in nearly every medical specialty to provide personalized, holistic care. Our nationally renowned cancer experts provide care for patients with all types of cancers, ranging from common cancers such as lymphomas, lung, breast, colorectal, and prostate cancers to far less common cancers such as melanomas originating in the eye and sarcomas. Innovative therapies are being evaluated through collaboration with the National Cancer Institute, various pharmaceutical companies and programs developed within our department and/or the Kimmel Cancer Center at Jefferson. Vaccine development and other forms of immunotherapy are under active investigation. Our medical oncologists also perform autologous and allogeneic bone marrow transplantations for selected forms of cancer.
Training the next generation of physicians and scientists including the next generation of thought leaders is also an important part of our mission. Our physicians provide didactic training and serve as role models for our students, residents, and fellows allowing them to develop their clinical and investigative skills under the watchful eye of a seasoned practitioner.
In all our efforts, our goal is to provide the best available today while making sure something even better is available tomorrow.
The Department of Medical Oncology is part of the award winning Kimmel Cancer Center at Jefferson and is proud of its status as a National Cancer Institute-designated Cancer Center. NCI-CC designated cancer centers were established to be national leaders in cancer treatment, research, and education. In addition, our Jefferson Infusion Centers in Center City and Methodist have earned The Joint Commission’s Gold Seal of Approval.
Neal Flomenberg, MD
Chair, Medical Oncology
Dr. Barbara Campling Quoted in HemOnc Today, "Zoledronic acid offered no significant survival benefit for patients with stage III NSCLC"